DiaMedica Therapeutics (DMAC) Shares Issued (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Shares Issued of $6.4 million for Q1 2026, up 26.8% year-over-year from $5.1 million in Q1 2025, and down 6.7% quarter-over-quarter from $6.9 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Shares Issued (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- In Q1 2026, Shares Issued rose 26.8% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (up 26.8% YoY), while the FY2025 annual figure was $6.9 million, up 46.3% from the prior year.
- Shares Issued for Q1 2026 stood at $6.4 million, down from $6.9 million in the prior quarter.
- The five-year high for Shares Issued was $7.3 million in Q3 2025, with the low at $2.2 million in Q1 2022.
- The 5-year median for Shares Issued is $4.3 million (2024), against an average of $4.4 million.
- The sharpest annual moves came in 2022 and 2025: Shares Issued surged 84.65% in 2022, then grew 18.58% in 2025.
- DiaMedica Therapeutics' Shares Issued stood at $2.8 million in 2022, then soared by 39.13% to $3.9 million in 2023, then increased by 21.22% to $4.7 million in 2024, then surged by 46.3% to $6.9 million in 2025, then fell by 6.7% to $6.4 million in 2026.
- Business Quant data shows DMAC's Shares Issued at $6.4 million in Q1 2026, $6.9 million in Q4 2025, and $7.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 8.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.18 Mn |
| Jun 30, 2026 | 8.18 Mn |
| Mar 31, 2026 | 6.41 Mn |
| Mar 31, 2026 | 6.41 Mn |
| Dec 31, 2025 | 6.86 Mn |
| Dec 31, 2025 | 6.86 Mn |
| Sep 30, 2025 | 7.32 Mn |
| Sep 30, 2025 | 7.32 Mn |
| Jun 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 6.69 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 4.63 Mn |
| Sep 30, 2024 | 4.63 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Mar 31, 2024 | 4.26 Mn |